RKDA

$1.72

Market ClosedAs of Mar 17, 8:00 PM UTC

Arcadia Biosciences, Inc.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.72
Potential Upside
5%
Whystock Fair Value$1.81
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorConsumer Defensive
IndustryPackaged Foods

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as wel...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.75M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.61
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-64.65%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
2.94

Recent News

Associated Press Finance
Nov 7, 2025

Arcadia Biosciences: Q3 Earnings Snapshot

DALLAS (AP) — Arcadia Biosciences Inc. RKDA) on Friday reported earnings of $856,000 in its third quarter. The Dallas-based company said it had net income of 62 cents per share.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Associated Press Finance
Aug 15, 2025

Arcadia Biosciences: Q2 Earnings Snapshot

DALLAS (AP) — Arcadia Biosciences Inc. RKDA) on Thursday reported a loss of $4.5 million in its second quarter. On a per-share basis, the Dallas-based company said it had a loss of $3.26.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
GuruFocus.com
May 9, 2025

Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Call Highlights: Strong Zola Sales and ...

Arcadia Biosciences Inc (RKDA) reports significant growth in Zola coconut water sales and strategic financial maneuvers, despite facing margin pressures and delayed product launches.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Associated Press Finance
May 8, 2025

Arcadia Biosciences: Q1 Earnings Snapshot

DALLAS (AP) — Arcadia Biosciences Inc. RKDA) on Thursday reported earnings of $2.6 million in its first quarter. On a per-share basis, the Dallas-based company said it had profit of $1.90.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
GuruFocus.com
Mar 21, 2025

Arcadia Biosciences Inc (RKDA) Q4 2024 Earnings Call Highlights: Strong Zola Sales Propel ...

Arcadia Biosciences Inc (RKDA) reports a 56% increase in Q4 revenue driven by Zola's impressive sales growth, despite facing declines in GLA oil sales and increased transaction costs.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.